You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
博騰股份(300363.SZ):擬向子公司博騰生物研究院和蘇州博騰生物增資
格隆匯 07-23 17:09

格隆匯 7 月 23日丨博騰股份(300363.SZ)公佈,公司召開第四屆董事會第十八次臨時會議,審議通過了《關於向子公司博騰生物研究院和蘇州博騰生物增資的議案》。

為促進公司生物CDMO業務發展,滿足二級控股子公司蘇州博騰生物製藥有限公司(“蘇州博騰生物”)2020年資本性支出及其他運營支出所需的資金需求,同意公司對全資子公司重慶博騰生物醫學研究院有限公司(“博騰生物研究院”)增資3000萬人民幣,用於其向其控股子公司蘇州博騰生物增資4000萬人民幣。此次增資完成後,博騰生物研究院的註冊資本將由9000萬人民幣增至1.2億人民幣,蘇州博騰生物的註冊資本將由1億人民幣增加為1.4億人民幣,博騰生物研究院持有蘇州博騰生物的股權比例將增至81.79%。此次增資不會對公司2020年財務狀況和經營業績產生重大影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account